Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 57

1.

Globotriaosylsphingosine (Lyso-Gb3) as a biomarker for cardiac variant (N215S) Fabry disease.

Alharbi FJ, Baig S, Auray-Blais C, Boutin M, Ward DG, Wheeldon N, Steed R, Dawson C, Hughes D, Geberhiwot T.

J Inherit Metab Dis. 2018 Mar;41(2):239-247. doi: 10.1007/s10545-017-0127-2. Epub 2018 Jan 2.

PMID:
29294190
2.

The 2017 international classification of the Ehlers-Danlos syndromes.

Malfait F, Francomano C, Byers P, Belmont J, Berglund B, Black J, Bloom L, Bowen JM, Brady AF, Burrows NP, Castori M, Cohen H, Colombi M, Demirdas S, De Backer J, De Paepe A, Fournel-Gigleux S, Frank M, Ghali N, Giunta C, Grahame R, Hakim A, Jeunemaitre X, Johnson D, Juul-Kristensen B, Kapferer-Seebacher I, Kazkaz H, Kosho T, Lavallee ME, Levy H, Mendoza-Londono R, Pepin M, Pope FM, Reinstein E, Robert L, Rohrbach M, Sanders L, Sobey GJ, Van Damme T, Vandersteen A, van Mourik C, Voermans N, Wheeldon N, Zschocke J, Tinkle B.

Am J Med Genet C Semin Med Genet. 2017 Mar;175(1):8-26. doi: 10.1002/ajmg.c.31552.

PMID:
28306229
3.

Diagnosis, natural history, and management in vascular Ehlers-Danlos syndrome.

Byers PH, Belmont J, Black J, De Backer J, Frank M, Jeunemaitre X, Johnson D, Pepin M, Robert L, Sanders L, Wheeldon N.

Am J Med Genet C Semin Med Genet. 2017 Mar;175(1):40-47. doi: 10.1002/ajmg.c.31553. Review.

PMID:
28306228
4.

4 years' cascade genetic testing for familial hypercholesterolaemia in England - Increased referrals and ascertainment.

Hills A, Honeychurch J, Davies J, Robinson C, Bayly G, Taylor A, Barbir M, Breen J, Watson M, Wheeldon N, Williams M.

Atherosclerosis. 2016 Dec;255:3. doi: 10.1016/j.atherosclerosis.2016.09.051. Epub 2016 Dec 4. No abstract available.

PMID:
28327396
5.

Diagnostic yield of molecular autopsy in patients with sudden arrhythmic death syndrome using targeted exome sequencing.

Nunn LM, Lopes LR, Syrris P, Murphy C, Plagnol V, Firman E, Dalageorgou C, Zorio E, Domingo D, Murday V, Findlay I, Duncan A, Carr-White G, Robert L, Bueser T, Langman C, Fynn SP, Goddard M, White A, Bundgaard H, Ferrero-Miliani L, Wheeldon N, Suvarna SK, O'Beirne A, Lowe MD, McKenna WJ, Elliott PM, Lambiase PD.

Europace. 2016 Jun;18(6):888-96. doi: 10.1093/europace/euv285. Epub 2015 Oct 25.

6.

Outcomes of Primary Percutaneous Coronary Intervention for Patients with Previous Coronary Artery Bypass Grafting Presenting with STsegment Elevation Myocardial Infarction.

Garg P, Kamaruddin H, Iqbal J, Wheeldon N.

Open Cardiovasc Med J. 2015 Dec 18;9:99-104. doi: 10.2174/1874192401509010099. eCollection 2015.

7.

Spontaneous coronary artery dissection.

Salhiyyah K, Abunasra H, Waqar S, Wheeldon N, Sarkar P.

Gen Thorac Cardiovasc Surg. 2009 Oct;57(10):540-3. doi: 10.1007/s11748-009-0416-2. Epub 2009 Oct 16.

PMID:
19830517
8.
9.

Effects of succinobucol (AGI-1067) after an acute coronary syndrome: a randomised, double-blind, placebo-controlled trial.

Tardif JC, McMurray JJ, Klug E, Small R, Schumi J, Choi J, Cooper J, Scott R, Lewis EF, L'Allier PL, Pfeffer MA; Aggressive Reduction of Inflammation Stops Events (ARISE) Trial Investigators.

Lancet. 2008 May 24;371(9626):1761-8. doi: 10.1016/S0140-6736(08)60763-1.

PMID:
18502300
10.

Risk factors for bleeding during anticoagulation of atrial fibrillation in older and younger patients in clinical practice.

Abdelhafiz AH, Wheeldon NM.

Am J Geriatr Pharmacother. 2008 Mar;6(1):1-11. doi: 10.1016/j.amjopharm.2008.03.005.

PMID:
18396243
11.

Comparison of idraparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: a randomised, open-label, non-inferiority trial.

Amadeus Investigators, Bousser MG, Bouthier J, Büller HR, Cohen AT, Crijns H, Davidson BL, Halperin J, Hankey G, Levy S, Pengo V, Prandoni P, Prins MH, Tomkowski W, Torp-Pedersen C, Wyse DG.

Lancet. 2008 Jan 26;371(9609):315-21. doi: 10.1016/S0140-6736(08)60168-3. Erratum in: Lancet. 2008 Dec 13;372(9655):2022.. Thorp-Pedersen, C [corrected to Torp-Pedersen, C].

PMID:
18294998
12.

Hemodynamic assessment of mitral mechanical prostheses under high flow conditions: comparison between dynamic exercise and dobutamine stress.

Hobson NA, Wilkinson GA, Cooper GJ, Wheeldon NM, Lynch J.

J Heart Valve Dis. 2006 Jan;15(1):87-91.

PMID:
16480017
13.

Anticoagulation of atrial fibrillation in older people: a clinical practice observational study.

Abdelhafiz AH, Wheeldon NM.

J Am Geriatr Soc. 2006 Jan;54(1):176-7. No abstract available.

PMID:
16420226
14.

Hemodynamic performance of the Ultracor and Carpentier-Edwards aortic prostheses using exercise and dobutamine stress echocardiography.

Hobson NA, Wilkinson GA, Wheeldon NM, Lynch J.

J Heart Valve Dis. 2005 Nov;14(6):828-34.

PMID:
16359066
15.

Active inflammatory bowel disease and coronary artery dissection.

Srinivas M, Basumani P, Muthusamy R, Wheeldon N.

Postgrad Med J. 2005 Jan;81(951):68-70.

16.
18.

Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both.

Pfeffer MA, McMurray JJ, Velazquez EJ, Rouleau JL, Køber L, Maggioni AP, Solomon SD, Swedberg K, Van de Werf F, White H, Leimberger JD, Henis M, Edwards S, Zelenkofske S, Sellers MA, Califf RM; Valsartan in Acute Myocardial Infarction Trial Investigators.

N Engl J Med. 2003 Nov 13;349(20):1893-906. Epub 2003 Nov 10. Erratum in: N Engl J Med. 2004 Jan 8;350(2):203.

19.

Microalbuminuria reduction with valsartan in patients with type 2 diabetes mellitus: a blood pressure-independent effect.

Viberti G, Wheeldon NM; MicroAlbuminuria Reduction With VALsartan (MARVAL) Study Investigators.

Circulation. 2002 Aug 6;106(6):672-8.

20.

Coronary angiography using 4 French catheters.

Wheeldon NM.

Int J Cardiol. 2001 Aug;80(1):5-6. No abstract available.

PMID:
11532540

Supplemental Content

Loading ...
Support Center